Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011849 (
diabetes
)
277,896
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bardet-Biedl syndrome (BBS)
is a rare autosomal recessive genetic disorder. It is a congenital ciliopathy that has primary and secondary characteristics. Primary clinical features include rod-cone dystrophy, polydactyly, central obesity, genital abnormalities and mental retardation often presenting as learning difficulties. Secondary clinical features include developmental delay, speech deficit, brachydactyly/syndactyly, dental defects, ataxia, olfactory deficit,
diabetes mellitus
(DM) and congenital heart disease.
BBS
patients are friendly with a happy predisposition. Proper management, and regular examinations should be done in order to maintain healthy organ function and to avoid an early death. Renal failure is the most common cause of mortality in
BBS
patients.This case report illustrates the evaluation of a child with
BBS
, as well as the unique association of otolaryngologic symptoms and bronchopneumonia with it.
...
PMID:A Unique Manifestation of Bardet-Biedl Syndrome with Otolaryngologic Symptoms and Bronchopneumonia in a One-year-old Girl. 3172 Jan 85
Bardet-Biedl syndrome (BBS)
is a rare autosomal recessively inherited disease with major clinical symptoms such as: obesity, retinal degeneration, polydactyly and renal abnormalities. The aim of the study was to assess the spectrum of gene variants among patients with
BBS
, identified on the basis of nationwide genetic studies of monogenic
diabetes
in Polish population. Out of 575 patients enrolled for genetic testing from February 2017 to July 2019, 25 patients with a clinical suspicion of
BBS
were selected. The identification of pathogenic variants was performed by using targeted next-generation sequencing (NGS) on Illumina NextSeq 550 platform involving the SureSelect assay (Agilent, Santa Clara, CA, USA).
BBS
was genetically confirmed in 10 of 25 suspected patients. In patients, 14 different variants were found in six genes, mainly in
BBS9
and
BBS10
gene, including two novel variants. A strong association between hyperglycemia and insulin resistance in patients and the presence of variants in
BBS9
gene was observed. Identification of 14 variants, including two new mutations using the NGS method, is the first molecular characteristic of Polish patients with
Bardet-Biedl syndrome
. It gives hope for earlier proper diagnosis of
BBS
in future patients selected from children with early childhood obesity and their medical multidisciplinary care.
...
PMID:Next-Generation Sequencing in the Diagnosis of Patients with Bardet-Biedl Syndrome-New Variants and Relationship with Hyperglycemia and Insulin Resistance. 3313 63
Laurence-Moon-Bardet-Biedl syndrome
(LMBBS), a rare autosomal recessive genetic disorder, results from consanguineous marriage. It is a congenital ciliopathy manifesting with primary and secondary characteristics. Primary clinical features include rod and cone dystrophy, polydactyly, central obesity, genital abnormalities, and mental retardation, often presenting as poor schooling skills. Secondary clinical features include developmental delay, speech deficit, brachydactyly/syndactyly, dental defects, ataxia, olfactory deficit,
diabetes mellitus
(DM), and congenital heart disease. Herein, we report a case of a 15-year-old male with clinical manifestations of LMBBS, namely learning disabilities, night blindness, hypogonadism, polydactyly, polysyndactyly, and obesity. Physicians must be familiar with this syndrome, for which an early diagnosis, multidisciplinary approach, and regular follow-ups can profoundly diminish morbidity and mortality in LMBBS patients.
...
PMID:Laurence-Moon-Bardet-Biedl Syndrome: A Rare Case With a Literature Review. 3330 90
<< Previous
1
2
3
4
5
6
7